Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$273,280
+$64,708 QoQ
Shares Held
1,086
+13.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,641
of 1,872 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sachetta, LLC holds $1,910,793 across 12 Drug Manufacturers - General names. ABBV ranks #4 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,158 | $548,066 | |
| 2 | LLY |
ELI LILLY & Co
|
314 | $376,620 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,226 | $286,040 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
1,086 | $273,280 | |
| 5 | AMGN |
Amgen Inc
|
556 | $201,337 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
757 | $95,639 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
994 | $57,273 | |
| 8 | PFE |
Pfizer Inc
|
1,739 | $41,874 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $273,280 | 1,086 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $208,572 | 959 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $248,596 | 1,088 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,184,326 | 5,115 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $947,404 | 5,104 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,140,417 | 5,443 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $986,767 | 5,553 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,143,013 | 5,788 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $958,281 | 5,587 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $959,120 | 5,267 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $816,226 | 5,267 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||